Latest Advances

  • Condition: Middle Cerebral Artery Stroke
  • Journal: Neurosurgical focus
  • Treatment Used: Mechanical Thrombectomy vs. Mechanical Thrombectomy with Bridging Thrombolysis
  • Number of Patients: 2895
  • Published —
The aim of this study was to compare the safety and outcomes of mechanical thrombectomy (MT) alone versus mechanical thrombectomy with bridging intravenous thrombolysis (IVT) in patients with acute ischemic stroke (AIS) due to large-vessel occlusion (LVO) in the middle cerebral artery (MCA).
  • Condition: Prevention of Recurrent Ischemic Neurological Events
  • Journal: Medicine
  • Treatment Used: Patent Foramen Ovale (PFo) Closure vs. Medical Therapy
  • Number of Patients: 0
  • Published —
This review of the literature evaluated the effect of patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent ischemic neurological events.
  • Condition: Patients with Atrial Fibrillation (AF) and Severe Renal Dysfunction
  • Journal: The Israel Medical Association journal : IMAJ
  • Treatment Used: Apixaban
  • Number of Patients: 254
  • Published —
This study evaluated the outcomes of patients with atrial fibrillation (AF) and severe renal dysfunction treated with apixaban.
  • Condition: Intracardiac Thrombus in Patient with Mitral Bioprosthesis and Atrial Fibrillation (AF)
  • Journal: Medicine
  • Treatment Used: Direct Anticoagulant Therapy
  • Number of Patients: 1
  • Published —
This case report describes a 50-year-old woman with mitral bioprosthesis under warfarin for nonvalvular atrial fibrillation treated with direct oral anticoagulation.
  • Condition: Taiwanese Patients with Nonvalvular Atrial Fibrillation (AF)
  • Journal: Medicine
  • Treatment Used: Off-Label Reduced-Dose Apixaban
  • Number of Patients: 1073
  • Published —
This study investigated the safety and effectiveness of off-label reduced-dose apixaban in the treatment of Taiwanese patients with nonvalvular atrial fibrillation (heart quivering; AF).
  • Condition: New-Onset Atrial Fibrillation (NOAF) in Patients With Primary Aldosteronism (PA)
  • Journal: Frontiers in endocrinology
  • Treatment Used: Different Treatment Strategies
  • Number of Patients: 2705
  • Published —
This review of the literature investigated the rate of new-onset atrial fibrillation (heart quivering; NOAF) in patients with primary aldosteronism (PA) receiving mineralocorticoid receptor antagonist (MRA) versus adrenalectomy.
  • Journal: BMJ case reports
  • Published —
Congenitally corrected transposition of the great arteries (CCTGA).
  • Condition: Prevention of Atrial Fibrillation (AF) Recurrence in Patients with Hypertension and Atrial Fibrillation
  • Journal: Cardiovascular therapeutics
  • Treatment Used: Angiotensin Receptor Blocker (ARB) and Calcium Channel Blocker (CCB)
  • Number of Patients: 1495
  • Published —
This study evaluated the effect of angiotensin receptor blocker (ARB) or calcium channel blocker (CCB) on atrial fibrillation (heart quivering; AF) recurrence in patients with hypertension (high blood pressure) and atrial fibrillation.
Showing 1-12 of 1147